DCF Advisers, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$157,000
-10.3%
13,100
-6.4%
0.06%
-26.3%
Q1 2021$175,000
-19.7%
14,0000.0%0.08%
-15.6%
Q4 2020$218,000
-42.9%
14,000
-65.3%
0.09%
-53.8%
Q3 2020$382,000
-39.5%
40,400
-42.6%
0.20%
-44.8%
Q2 2020$631,000
+84.0%
70,400
+30.6%
0.35%
+57.6%
Q1 2020$343,000
-40.3%
53,900
-21.5%
0.22%
-38.6%
Q4 2019$575,00068,7000.36%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders